Indian Journal of Urology Users online:1668  
IJU
Home Current Issue Ahead of print Editorial Board Archives Symposia Guidelines Subscriptions Login 
Print this page  Email this page Small font sizeDefault font sizeIncrease font size


 
  Table of Contents 
LETTERS TO EDITOR
Year : 2022  |  Volume : 38  |  Issue : 2  |  Page : 162-163
 

Re: Mahajan AD, Mahajan SA. Thulium fiber laser versus holmium:yttrium aluminum garnet laser for stone lithotripsy during mini-percutaneous nephrolithotomy: A prospective randomized trial. Indian J Urol 2022;38:42-7


Department of Urology, Christian Medical College, Vellore, Tamil Nadu, India

Date of Submission24-Feb-2022
Date of Acceptance19-Mar-2022
Date of Web Publication1-Apr-2022

Correspondence Address:
Sudhindra Jayasimha
Department of Urology, Christian Medical College, Vellore, Tamil Nadu
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/iju.iju_67_22

Rights and Permissions

 

How to cite this article:
Jayasimha S. Re: Mahajan AD, Mahajan SA. Thulium fiber laser versus holmium:yttrium aluminum garnet laser for stone lithotripsy during mini-percutaneous nephrolithotomy: A prospective randomized trial. Indian J Urol 2022;38:42-7. Indian J Urol 2022;38:162-3

How to cite this URL:
Jayasimha S. Re: Mahajan AD, Mahajan SA. Thulium fiber laser versus holmium:yttrium aluminum garnet laser for stone lithotripsy during mini-percutaneous nephrolithotomy: A prospective randomized trial. Indian J Urol 2022;38:42-7. Indian J Urol [serial online] 2022 [cited 2022 May 24];38:162-3. Available from: https://www.indianjurol.com/text.asp?2022/38/2/162/342463


We read the article, “Thulium fiber laser versus holmium: yttrium aluminum garnet laser for stone lithotripsy during mini-percutaneous nephrolithotomy: A prospective randomized trial,[1]” with interest. The authors have elegantly demonstrated that the thulium fiber laser (TFL) showed a shorter stone disintegration time (11 min 19 s vs. 20 min 45 s, P < 0.001) and operating time (55 vs. 68 min, P = 0.001) with similar stone clearance rates (94.9 TFL vs. 90.9% holmium:yttrium aluminum garnet [Ho-YAG]). Most complications were minor and self-limiting while hematuria was more common in the thulium laser fiber arm (13 vs. 2, P = 0.002). The following details, if added, will enhance the quality of the article and make it a valuable contribution to the level 1 evidence in this area, which is lacking. These are in keeping with the CONSORT statement:[2]

  1. Time period in which the study was carried out
  2. Clinical Trials Registry – India number
  3. Whether anomalous stone-bearing kidneys were excluded
  4. Exclusions because the patient did not consent or was to loss to follow-up
  5. Primary outcome
  6. Sample size calculation and assumption made based on published literature
  7. Details of when and who performed the randomization and allocation concealment
  8. Exclusions during the operation (for example, if conventional percutaneous nephrolithotomy (PCNL) was required instead of mini-PCNL after randomization)
  9. If the difference in stone clearance rates between the TFL group (94.9%) and the Ho-YAG group (90.9%) was statistically significant.


The authors have mentioned that the mean hemoglobin drop was 56 g/dL in the holmium arm and 55 g/dL in the thulium arm (the mean hemoglobin in the two groups was 13.3 g/dL and 13.2 g/dL, respectively). These values are high and may require to be corrected.

The authors are to be congratulated for reporting the first randomized study comparing TFL with Ho-YAG in mini-PCNL and for the demonstration of the superior stone fragmentation by TFL which merits further study.

Financial support and sponsorship:

Nil.

Conflicts of interest:

There are no conflicts of interest.

 
   References Top

1.
Mahajan AD, Mahajan SA. Thulium fiber laser versus holmium: Yttrium aluminum garnet laser for stone lithotripsy during mini-percutaneous nephrolithotomy: A prospective randomized trial. Indian J Urol 2022;38:42-7.  Back to cited text no. 1
  [Full text]  
2.
Schulz KF, Altman DG, Moher D; CONSORT Group. CONSORT 2010 statement: Updated guidelines for reporting parallel group randomised trials. BMJ 2010;340:c332.  Back to cited text no. 2
    




 

Top
Print this article  Email this article
 

    

 
   Search
 
  
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Article in PDF (304 KB)
    Citation Manager
    Access Statistics
    Reader Comments
    Email Alert *
    Add to My List *
* Registration required (free)  


    References

 Article Access Statistics
    Viewed362    
    Printed8    
    Emailed0    
    PDF Downloaded41    
    Comments [Add]    

Recommend this journal